Eventide Asset Management - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$44,032,000
-5.8%
1,600,000
+16.1%
0.79%
+0.1%
Q2 2023$46,746,718
-5.7%
1,377,7400.0%0.79%
-13.1%
Q1 2023$49,571,085
-24.0%
1,377,740
-5.8%
0.91%
-29.3%
Q4 2022$65,208,139
+29.5%
1,463,050
-18.3%
1.29%
+29.8%
Q3 2022$50,367,000
+29.2%
1,791,800
+23.9%
0.99%
+18.8%
Q2 2022$38,976,000
-20.8%
1,445,7000.0%0.83%
+8.0%
Q1 2022$49,241,000
+2.9%
1,445,700
+16.7%
0.77%
+26.1%
Q4 2021$47,871,000
-21.4%
1,238,900
+9.8%
0.61%
-23.8%
Q3 2021$60,901,000
-13.6%
1,128,000
-46.5%
0.80%
-15.2%
Q2 2021$70,522,000
+66.0%
2,108,908
+2.3%
0.95%
+50.3%
Q1 2021$42,486,000
+32.0%
2,062,433
+12.3%
0.63%
+27.5%
Q4 2020$32,186,000
+328.7%
1,837,108
+262.9%
0.49%
+236.1%
Q3 2020$7,507,000
+24.6%
506,179
+9.2%
0.15%
+12.2%
Q2 2020$6,023,000463,3350.13%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,200,000$88,064,00014.40%
Octagon Capital Advisors LP 759,898$20,912,3933.21%
TSP Capital Management Group, LLC 251,695$6,926,6452.67%
5AM Venture Management, LLC 310,270$8,538,6302.46%
COMMODORE CAPITAL LP 706,665$19,447,4212.27%
ACUTA CAPITAL PARTNERS, LLC 122,341$3,366,8242.26%
Redmile Group, LLC 1,635,938$45,021,0142.14%
RTW INVESTMENTS, LP 3,463,201$95,307,2922.01%
Eversept Partners, LP 588,143$16,185,6951.37%
Affinity Asset Advisors, LLC 150,000$4,128,0001.16%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders